Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 91259

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
December 06, 2022
Product types
Drug
Classifications
Class I
Statuses
Terminated
Recalling firm wording
Glaxosmithkline Consumer Healthcare Holdings DBA Haleon

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940

D-0181-2023
Recall number
D-0181-2023
Initiated
December 06, 2022
Classification
Class I
Status
Terminated
Quantity
321,246 tablets

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Code information

a) Lots EJ2218, EJ2219, EJ2220, Exp 09/2023; b) Lot 953D, Exp 05/2025

Distribution pattern

Nationwide in the USA.

drug · product 2 of 3

Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3

D-0182-2023
Recall number
D-0182-2023
Initiated
December 06, 2022
Classification
Class I
Status
Terminated
Quantity
88,380 capsules

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Code information

Lot: R94065, Exp 02/29/2024

Distribution pattern

Nationwide in the USA.

drug · product 3 of 3

Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5

D-0183-2023
Recall number
D-0183-2023
Initiated
December 06, 2022
Classification
Class I
Status
Terminated
Quantity
209,292 capsules

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Code information

Lot: R93517, R94072, R94073, Exp 02/29/2024; T00655, Exp 03/31/2025

Distribution pattern

Nationwide in the USA.

Field note

Send feedback

We'll only use this to respond to your feedback.